Is There A Class Action Lawsuit Against Bravecto? What Pet Owners Need To Know

Is there a recall on Bravecto for dogs? This question has been raised due to a recent FDA alert. In the alert, the FDA mentions several approved drugs belonging to the isoxazoline class, including Bravecto, Credelio, Nexgard, and Simparica. It’s important to note that as of September 21, 2018, these drugs have not been recalled or banned. However, the FDA has issued this alert to inform pet owners about potential concerns regarding these medications and their potential to cause issues in some pets.

Bravecto is a medication designed for dogs aged 8 weeks and older to protect them against various pests. While it is effective in many ways, there are some potential disadvantages to consider. The most frequently reported side effects of Bravecto 1-Month (fluralaner) Chews include itching, diarrhea, vomiting, decreased appetite, elevated ALT (alanine transaminase, a liver enzyme), lethargy, and weight loss. It’s important to note that Bravecto 1-Month is not effective against Amblyomma americanum ticks in puppies less than 6 months of age, so alternative tick control measures may be necessary for younger dogs. Understanding these potential drawbacks can help pet owners make informed decisions about their dog’s healthcare.